Ignite Creation Date:
2024-05-06 @ 7:18 AM
Last Modification Date:
2024-10-26 @ 11:47 AM
Study NCT ID:
NCT02507648
Status:
COMPLETED
Last Update Posted:
2015-07-24
First Post:
2015-07-22
Brief Title:
A Bioequivalence Study of Oseltamivir From Oseltamivir 75 mg Caps Pharmacare PLC Palestine and Tamiflu 75 mg Caps Hoffmann-La Roche Switzerland
Sponsor:
Organization:
Genuine Research Center Egypt
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
24
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE1 |
Observational Models:
Time Perspective List:
Who Masked List: